Cyclosporine Capsule, Liquid Filled
Product Images NDC 0093-9019

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclosporine (NDC 0093-9019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
FDA Label Image

1 (Image 3)

1 (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
FDA Label Image

1 (Image 5)

1 (Image 5)
CycloSPORINE Capsules USP MODIFIED are not bioequivalent to Sandimmune and should not be used interchangeably without physician supervision. The provided text also contains various symbols, numbers, and characters, making it difficult to provide a more specific description of its content.*
FDA Label Image

1 (Image 6)

1 (Image 6)
FDA Label Image

1 (Image 7)

1 (Image 7)
The text contains various non-sensical characters, numbers, and symbols. It also includes a warning regarding the use of CycloSPORINE Capsules USP MODIFIED and Sandimmune® (CycloSPORINE Capsules USP). The warning advises not to use them interchangeably without medical supervision. Therefore, the text does not provide any useful description and is not-available.*
FDA Label Image

1 (Image 8)

1 (Image 8)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.